{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:46:20Z","timestamp":1793115980193,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epstein\u2013Barr virus (EBV)\u2013associated gastric cancer (EBVaGC) is distinct molecular subtype of gastric cancer for which effective preventive and targeted therapeutic strategies remain limited. This study aimed to design and evaluate multiepitope vaccine candidates targeting four EBV proteins critically involved in this disease, namely BZLF1, EBNA1, LMP1, and LMP2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An integrated immunoinformatics and reverse vaccinology approach was employed to predict and screen MHC-I (CTL), MHC-II (HTL), and B-cell epitopes. Selected epitopes were assembled into multiepitope vaccine constructs, which were then evaluated for physicochemical properties, potential interactions with immune receptors, and post-injection immune responses using computational simulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 20 immunodominant epitopes in each CTL, HTL and LBL were identified and selected based on their predicted antigenicity, immunogenicity, non-allergenicity, and non-toxicity, while the selected MHC-II epitopes were additionally predicted to induce IFN-\u03b3, IL-2, IL-4, and IL-10 responses. Global population coverage analysis estimated worldwide coverage of 98.74%. The final vaccine construct comprised 1,091 amino acids and exhibited favorable physicochemical properties with acceptable structural quality, as indicated by a ProSA Z-score of \u2212\u20092.28 and 79.1% of residues located in the most favored regions of the Ramachandran plot. Disulfide engineering identified six residue pairs with the potential to enhance structural stability. Molecular docking demonstrated favorable binding of the vaccine construct to TLR9, with a HADDOCK score of \u2212\u2009165.4\u2009\u00b1\u20090.7\u00a0kcal\/mol. Molecular dynamics simulations further supported the structural feasibility of the vaccine\u2013TLR9 complex, yielding an average RMSD of 1.253\u00a0nm; 963.3 hydrogen bonds, and SASA of 911.3\u00a0nm\u00b2. Meanwhile, normal mode analysis corroborated the dynamic stability of the complex. Codon optimization in the pET-28a(+) vector resulted an optimal codon adaptation index (CAI\u2009=\u20091.0) and GC content of 57.86%, suggesting high potential for recombinant expression in\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      . Immune simulations further predicted coordinated humoral and cellular immune responses, accompanied by immunological memory formation following simulated vaccination regimen.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study proposed multiepitope vaccine candidate targeting crucial antigen of EBVaGC based immunoinformatics-based approach. The construct predicted to have favorable in silico immunological and structural properties. However, further experimental validation is required to confirm its safety and immunogenic potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00407-1","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:57:43Z","timestamp":1788512263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computationally guided multi-epitope vaccine design targeting oncoprotein BZLF1, EBNA1, LMP1, and LMP2 for of EBV associated gastric cancer"],"prefix":"10.1186","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8712-2317","authenticated-orcid":false,"given":"Elvin","family":"Delonio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5980-7525","authenticated-orcid":false,"given":"Ysrafil","family":"Ysrafil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herlina Eka","family":"Shinta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-8863","authenticated-orcid":false,"given":"Sari Eka","family":"Pratiwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"issue":"1","key":"407_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41021-025-00328-w","volume":"47","author":"Y Tan","year":"2025","unstructured":"Tan Y, Matsuzaki J, Saito Y, Suzuki H. Environmental factors in gastric carcinogenesis and preventive intervention strategies. Genes Environ. 2025;47(1):5. https:\/\/doi.org\/10.1186\/s41021-025-00328-w.","journal-title":"Genes Environ"},{"key":"407_CR2","doi-asserted-by":"publisher","first-page":"175883592513966","DOI":"10.1177\/17588359251396619","volume":"17","author":"H Al-Sattar","year":"2025","unstructured":"Al-Sattar H, Owen R, Jaafari AM, Saha A, Ayyappan K, Ghose A, et al. Therapeutic opportunities in EBV-positive gastric cancer subtypes. Ther Adv Med Oncol. 2025;17:17588359251396619. https:\/\/doi.org\/10.1177\/17588359251396619.","journal-title":"Ther Adv Med Oncol"},{"key":"407_CR3","doi-asserted-by":"publisher","unstructured":"Corallo S, Lasagna A, Filippi B, Alaimo D, Tortorella A, Serra F, et al. Unlocking the potential: Epstein-Barr virus (EBV) in gastric cancer and future treatment prospects, a literature review. Pathogens. 2024;13(9). https:\/\/doi.org\/10.3390\/pathogens13090728.","DOI":"10.3390\/pathogens13090728"},{"issue":"1","key":"407_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s12672-024-01619-4","volume":"15","author":"F Estaji","year":"2024","unstructured":"Estaji F, Zibaee S, Torabi M, Moghim S. Epstein-Barr virus and gastric carcinoma pathogenesis with emphasis on underlying epigenetic mechanisms. Discov Oncol. 2024;15(1):719. https:\/\/doi.org\/10.1007\/s12672-024-01619-4.","journal-title":"Discov Oncol"},{"issue":"1","key":"407_CR5","doi-asserted-by":"publisher","first-page":"42425","DOI":"10.1038\/s41598-025-26511-1","volume":"15","author":"M Zahraei","year":"2025","unstructured":"Zahraei M, Roohparvar Basmenj E, Behrouzi G, Heidari Keshel S, Alem M. In silico design of a multi-epitope vaccine against triple negative breast cancer. Sci Rep. 2025;15(1):42425. https:\/\/doi.org\/10.1038\/s41598-025-26511-1.","journal-title":"Sci Rep"},{"issue":"1","key":"407_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12672-022-00479-0","volume":"13","author":"\u00c1 Lima","year":"2022","unstructured":"Lima \u00c1, Sousa H, Medeiros R, Nobre A, Machado M. PD-L1 expression in EBV-associated gastric cancer: a systematic review and meta-analysis. Discov Oncol. 2022;13(1):19. https:\/\/doi.org\/10.1007\/s12672-022-00479-0.","journal-title":"Discov Oncol"},{"key":"407_CR7","doi-asserted-by":"publisher","unstructured":"Bai Y, Xie T, Wang Z, Tong S, Zhao X, Zhao F, et al. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer. J Immunother Cancer. 2022;10(3). https:\/\/doi.org\/10.1136\/jitc-2021-004080.","DOI":"10.1136\/jitc-2021-004080"},{"issue":"1","key":"407_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41419-025-08251-2","volume":"17","author":"B Huang","year":"2025","unstructured":"Huang B, Liu M, Duan Y, Guo J, Wang Z, Dou Y, et al. An EBNA1-YAP signaling axis drives immune escape through CD276 in EBV-associated gastric cancer. Cell Death Dis. 2025;17(1):118. https:\/\/doi.org\/10.1038\/s41419-025-08251-2.","journal-title":"Cell Death Dis"},{"key":"407_CR9","doi-asserted-by":"publisher","first-page":"1611991","DOI":"10.3389\/fonc.2025.1611991","volume":"15","author":"P Zhou","year":"2025","unstructured":"Zhou P, Shi X, Xia J, Hu H. In silico design and in vitro validation of a multi-epitope peptide vaccine targeting triple-negative breast cancer. Front Oncol. 2025;15:1611991. https:\/\/doi.org\/10.3389\/fonc.2025.1611991.","journal-title":"Front Oncol"},{"issue":"52","key":"407_CR10","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1016\/j.vaccine.2022.10.069","volume":"40","author":"W Qi","year":"2022","unstructured":"Qi W, Qingfeng L, Jing Z, Maolin Z, Zhihui Z, Wangqi D, et al. A novel multi-epitope vaccine of HPV16 E5E6E7 oncoprotein delivered by HBc VLPs induced efficient prophylactic and therapeutic antitumor immunity in tumor mice model. Vaccine. 2022;40(52):7693\u2013702. https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.069.","journal-title":"Vaccine"},{"key":"407_CR11","doi-asserted-by":"publisher","first-page":"197984","DOI":"10.1016\/j.virusres.2020.197984","volume":"284","author":"VV Kuprianov","year":"2020","unstructured":"Kuprianov VV, Nikolaeva LI, Zykova AA, Dedova AV, Grishechkin AE, Kapustin IV, et al. Combination of three adjuvants enhances the immunogenicity of a recombinant protein containing the CTL epitopes of non-structural proteins of hepatitis C virus. Virus Res. 2020;284:197984. https:\/\/doi.org\/10.1016\/j.virusres.2020.197984.","journal-title":"Virus Res"},{"issue":"3","key":"407_CR12","doi-asserted-by":"publisher","first-page":"500461","DOI":"10.1016\/j.vacun.2025.500461","volume":"26","author":"MN Mashrur","year":"2025","unstructured":"Mashrur MN, Hoque MN, Hasnat S, Saikat SH, Mehedi Hasan M, Hridy FK, Rani NA, Azam FMS. Development of a novel multi-epitope vaccine candidate for Marburg virus applying advanced immunoinformatics strategies: a computational analysis. Vacunas. 2025;26(3):500461. https:\/\/doi.org\/10.1016\/j.vacun.2025.500461.","journal-title":"Vacunas"},{"issue":"24","key":"407_CR13","doi-asserted-by":"publisher","first-page":"12543","DOI":"10.1128\/jvi.76.24.12543-12552.2002","volume":"76","author":"A Mauser","year":"2002","unstructured":"Mauser A, Holley-Guthrie E, Zanation A, Yarborough W, Kaufmann W, Klingelhutz A, et al. The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J Virol. 2002;76(24):12543\u201352. https:\/\/doi.org\/10.1128\/jvi.76.24.12543-12552.2002.","journal-title":"J Virol"},{"issue":"8","key":"407_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/labinvest.2015.69","volume":"95","author":"J Yang","year":"2015","unstructured":"Yang J, Deng W, Hau PM, Liu J, Lau VM, Cheung AL, et al. Epstein-Barr virus BZLF1 protein impairs accumulation of host DNA damage proteins at damage sites in response to DNA damage. Lab Invest. 2015;95(8):937\u201350. https:\/\/doi.org\/10.1038\/labinvest.2015.69.","journal-title":"Lab Invest"},{"issue":"6","key":"407_CR15","doi-asserted-by":"publisher","first-page":"e1000940","DOI":"10.1371\/journal.ppat.1000940","volume":"6","author":"QL Kong","year":"2010","unstructured":"Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, et al. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog. 2010;6(6):e1000940. https:\/\/doi.org\/10.1371\/journal.ppat.1000940.","journal-title":"PLoS Pathog"},{"issue":"1","key":"407_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2013.05.018","volume":"337","author":"T Yoshizaki","year":"2013","unstructured":"Yoshizaki T, Kondo S, Wakisaka N, Murono S, Endo K, Sugimoto H, et al. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Lett. 2013;337(1):1\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2013.05.018.","journal-title":"Cancer Lett"},{"issue":"47","key":"407_CR17","doi-asserted-by":"publisher","first-page":"32043","DOI":"10.1021\/acsomega.1c04817","volume":"6","author":"SA Sami","year":"2021","unstructured":"Sami SA, Marma KKS, Mahmud S, Khan MAN, Albogami S, El-Shehawi AM, et al. Designing a multi-epitope vaccine against the structural proteins of Marburg virus exploiting the immunoinformatics approach. ACS Omega. 2021;6(47):32043\u201371. https:\/\/doi.org\/10.1021\/acsomega.1c04817.","journal-title":"ACS Omega"},{"issue":"5","key":"407_CR18","doi-asserted-by":"publisher","first-page":"27846","DOI":"10.34172\/bi.2024.27846","volume":"14","author":"SE Pratiwi","year":"2024","unstructured":"Pratiwi SE, Ysrafil Y, Mardhia M, Mahyarudin M, Ilmiawan MI, Trianto HF, et al. A novel therapeutic multiepitope vaccine based on oncoprotein E6 and E7 of HPV 16 and 18: an in silico approach. BioImpacts. 2024;14(5):27846. https:\/\/doi.org\/10.34172\/bi.2024.27846.","journal-title":"BioImpacts"},{"issue":"5","key":"407_CR19","doi-asserted-by":"publisher","first-page":"e0115122","DOI":"10.1128\/spectrum.01151-22","volume":"10","author":"AT Moin","year":"2022","unstructured":"Moin AT, Patil RB, Tabassum T, Araf Y, Ullah MA, Snigdha HJ, et al. Immunoinformatics approach to design novel subunit vaccine against the Epstein-Barr virus. Microbiol Spectr. 2022;10(5):e0115122. https:\/\/doi.org\/10.1128\/spectrum.01151-22.","journal-title":"Microbiol Spectr"},{"issue":"4","key":"407_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.24171\/j.phrp.2024.0026","volume":"15","author":"MF Nugraha","year":"2024","unstructured":"Nugraha MF, Changestu DA, Ramadhan R, Salsabila T, Nurizati A, Pratiwi SE, et al. Novel prophylactic and therapeutic multi-epitope vaccine based on Ag85A, Ag85B, ESAT-6, and CFP-10 of Mycobacterium tuberculosis using an immunoinformatics approach. Osong Public Health Res Perspect. 2024;15(4):286\u2013306. https:\/\/doi.org\/10.24171\/j.phrp.2024.0026.","journal-title":"Osong Public Health Res Perspect"},{"issue":"4","key":"407_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.24171\/j.phrp.2024.0013","volume":"15","author":"N Ryan","year":"2024","unstructured":"Ryan N, Pratiwi SE, Mardhia M, Ysrafil Y, Liana DF, Mahyarudin M. Immunoinformatics approach for design novel multi-epitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer. Osong Public Health Res Perspect. 2024;15(4):307\u201328. https:\/\/doi.org\/10.24171\/j.phrp.2024.0013.","journal-title":"Osong Public Health Res Perspect"},{"issue":"4","key":"407_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00894-023-05503-w","volume":"29","author":"M Bhattacharjee","year":"2023","unstructured":"Bhattacharjee M, Banerjee M, Mukherjee A. In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross-immunity against human visceral and cutaneous leishmaniasis: an immunoinformatics-based approach. J Mol Model. 2023;29(4):99. https:\/\/doi.org\/10.1007\/s00894-023-05503-w.","journal-title":"J Mol Model"},{"key":"407_CR23","doi-asserted-by":"publisher","first-page":"100500","DOI":"10.1016\/j.imu.2020.100500","volume":"22","author":"MS Hossain","year":"2021","unstructured":"Hossain MS, Hossan MI, Mizan S, Moin AT, Yasmin F, Akash AS, et al. Immunoinformatics approach to designing a multi-epitope vaccine against Saint Louis Encephalitis Virus. Inf Med Unlocked. 2021;22:100500. https:\/\/doi.org\/10.1016\/j.imu.2020.100500.","journal-title":"Inf Med Unlocked"},{"key":"407_CR24","doi-asserted-by":"publisher","first-page":"26443","DOI":"10.34172\/bi.2023.26443","volume":"15","author":"Y Ysrafil","year":"2025","unstructured":"Ysrafil Y, Imran AK, Wicita PS, Kamba V, Mohamad F, Ismail I, et al. Mosaic vaccine design targeting mutational spike protein of SARS-CoV-2: An immunoinformatics approach. BioImpacts. 2025;15:26443. https:\/\/doi.org\/10.34172\/bi.2023.26443.","journal-title":"BioImpacts"},{"issue":"4","key":"407_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.34172\/bi.2022.23769","volume":"12","author":"Y Ysrafil","year":"2022","unstructured":"Ysrafil Y, Sapiun Z, Astuti I, Anasiru MA, Slamet NS, Hartati H, et al. Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach. BioImpacts. 2022;12(4):359\u201370. https:\/\/doi.org\/10.34172\/bi.2022.23769.","journal-title":"BioImpacts"},{"key":"407_CR26","doi-asserted-by":"publisher","first-page":"1269774","DOI":"10.3389\/fimmu.2023.1269774","volume":"14","author":"QR Jyotisha","year":"2023","unstructured":"Jyotisha QR, Qureshi IA. Development of a multi-epitope vaccine candidate for leishmanial parasites applying immunoinformatics and in vitro approaches. Front Immunol. 2023;14:1269774. https:\/\/doi.org\/10.3389\/fimmu.2023.1269774.","journal-title":"Front Immunol"},{"key":"407_CR27","doi-asserted-by":"publisher","first-page":"111655","DOI":"10.1016\/j.molbiopara.2024.111655","volume":"260","author":"N Ahmed","year":"2024","unstructured":"Ahmed N, Rani NA, Robin TB, Mashrur MN, Shovo MMI, Prome AA, Sultana S, Nazneen Akhand MR. Designing a multi-epitope subunit vaccine against Toxoplasma gondii through reverse vaccinology approach. Mol Biochem Parasitol. 2024;260:111655. https:\/\/doi.org\/10.1016\/j.molbiopara.2024.111655.","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"407_CR28","doi-asserted-by":"publisher","first-page":"42169","DOI":"10.1038\/s41598-025-26139-1","volume":"15","author":"MN Mashrur","year":"2025","unstructured":"Mashrur MN, Imranuzzaman M, Barua H, Hasan MR, Hridy FK, Sakib TS, Rani NA, Rahman M, Ahsan G, Ashraf T, Muktadir S, Belal AB, Roy A, Mohiuddin ASM, Shishir TA, Hossain H, Rahman MM, Akhand MRN, Rahman MM. In silico design of novel multi-epitope peptide vaccine against Neospora caninum induced cattle abortion targeting extracellular GRA2 and Nc-p43 protein. Sci Rep. 2025;15(1):42169. https:\/\/doi.org\/10.1038\/s41598-025-26139-1.","journal-title":"Sci Rep"},{"key":"407_CR29","doi-asserted-by":"publisher","unstructured":"Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinf. 2016;54(1). https:\/\/doi.org\/10.1002\/cpbi.3. 5.6.1\u20135.6.37.","DOI":"10.1002\/cpbi.3"},{"issue":"13","key":"407_CR30","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera\u2014A visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605\u201312. https:\/\/doi.org\/10.1002\/jcc.20084.","journal-title":"J Comput Chem"},{"key":"407_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001.","journal-title":"SoftwareX"},{"key":"407_CR32","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1016\/j.csbj.2023.09.024","volume":"21","author":"AA Yekeen","year":"2023","unstructured":"Yekeen AA, Durojaye OA, Idris MO, Muritala HF, Arise RO. CHAPERONg: A tool for automated GROMACS-based molecular dynamics simulations and trajectory analyses. Comput Struct Biotechnol J. 2023;21:4849\u201358. https:\/\/doi.org\/10.1016\/j.csbj.2023.09.024.","journal-title":"Comput Struct Biotechnol J"},{"issue":"15","key":"407_CR33","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.3390\/cancers16152692","volume":"16","author":"M Ratti","year":"2024","unstructured":"Ratti M, Orlandi E, Toscani I, Vecchia S, Anselmi E, Hahne JC, et al. Emerging therapeutic targets and future directions in advanced gastric cancer: A comprehensive review. Cancers. 2024;16(15):2692. https:\/\/doi.org\/10.3390\/cancers16152692.","journal-title":"Cancers"},{"issue":"7","key":"407_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1158\/2326-6066.CIR-14-0242","volume":"3","author":"AS Hartlage","year":"2015","unstructured":"Hartlage AS, Liu T, Patton JT, Garman SL, Zhang X, Kurt H, et al. The Epstein\u2013Barr virus lytic protein BZLF1 as a candidate target antigen for vaccine development. Cancer Immunol Res. 2015;3(7):787\u201394. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0242.","journal-title":"Cancer Immunol Res"},{"key":"407_CR35","doi-asserted-by":"publisher","DOI":"10.1201\/9781315533247","volume-title":"Janeway\u2019s Immunobiology","author":"K Murphy","year":"2016","unstructured":"Murphy K, Weaver C. Janeway\u2019s Immunobiology. 9th ed. New York: Garland Science; 2016.","edition":"9"},{"issue":"W1","key":"407_CR36","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson B, Alvarez B, Paul S, Peters B, Nielsen M. NetMHCpan-4.1 and NetMHCIIpan-4.0: Improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 2020;48(W1):W449\u201354. https:\/\/doi.org\/10.1093\/nar\/gkaa379.","journal-title":"Nucleic Acids Res"},{"key":"407_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8:4. https:\/\/doi.org\/10.1186\/1471-2105-8-4.","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"407_CR38","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/all.14840","volume":"76","author":"V Sampath","year":"2021","unstructured":"Sampath V, Rabinowitz G, Shah M, Jain S, Diamant Z, Jesenak M, et al. Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives. Allergy. 2021;76(6):1640\u201360. https:\/\/doi.org\/10.1111\/all.14840.","journal-title":"Allergy"},{"issue":"3","key":"407_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/ph15030323","volume":"15","author":"AA Robles-Loaiza","year":"2022","unstructured":"Robles-Loaiza AA, Pinos-Tamayo EA, Mendes B, Ortega-Pila JA, Proa\u00f1o-Bola\u00f1os C, Plisson F, et al. Traditional and computational screening of non-toxic peptides and approaches to improving selectivity. Pharmaceuticals (Basel). 2022;15(3):323. https:\/\/doi.org\/10.3390\/ph15030323.","journal-title":"Pharmaceuticals (Basel)"},{"key":"407_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross SH, Cantrell DA. Signaling and function of interleukin-2 in T lymphocytes. Annu Rev Immunol. 2018;36:411\u201333. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053352.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"407_CR41","first-page":"94","volume":"16","author":"DR Budiani","year":"2011","unstructured":"Budiani DR, Haryana SM, Sosroseno W. Interleukin-4 and interferon-\u03b3 levels in Epstein-Barr virus-associated infectious mononucleosis and nasopharyngeal carcinoma. J Res Med Sci. 2011;16(1):94\u20137.","journal-title":"J Res Med Sci"},{"issue":"9","key":"407_CR42","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.trecan.2023.05.003","volume":"9","author":"MA Salkeni","year":"2023","unstructured":"Salkeni MA, Naing A. Interleukin-10 in cancer immunotherapy: From bench to bedside. Trends Cancer. 2023;9(9):716\u201325. https:\/\/doi.org\/10.1016\/j.trecan.2023.05.003.","journal-title":"Trends Cancer"},{"key":"407_CR43","doi-asserted-by":"publisher","first-page":"8437","DOI":"10.2147\/OTT.S221340","volume":"12","author":"J Cai","year":"2019","unstructured":"Cai J, Wang D, Zhang G, Guo X. The role of PD-1\/PD-L1 axis in Treg development and function: Implications for cancer immunotherapy. Onco Targets Ther. 2019;12:8437\u201345. https:\/\/doi.org\/10.2147\/OTT.S221340.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"407_CR44","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/jid.2012.319","volume":"133","author":"LK Ferris","year":"2013","unstructured":"Ferris LK, Mburu YK, Mathers AR, Fluharty ER, Larregina AT, Ferris RL, et al. Human beta-defensin 3 induces maturation of human Langerhans cell-like dendritic cells: An antimicrobial peptide that functions as an endogenous adjuvant. J Invest Dermatol. 2013;133(2):460\u20138. https:\/\/doi.org\/10.1038\/jid.2012.319.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"407_CR45","doi-asserted-by":"publisher","first-page":"24485","DOI":"10.1038\/s41598-021-03932-2","volume":"11","author":"H Tarrahimofrad","year":"2021","unstructured":"Tarrahimofrad H, Rahimnahal S, Zamani J, Jahangirian E, Aminzadeh S. Designing a multi-epitope vaccine to provoke robust immune response against influenza A H7N9. Sci Rep. 2021;11(1):24485. https:\/\/doi.org\/10.1038\/s41598-021-03932-2.","journal-title":"Sci Rep"},{"issue":"1","key":"407_CR46","doi-asserted-by":"publisher","first-page":"16798","DOI":"10.1038\/s41598-024-66828-x","volume":"14","author":"EK Oladipo","year":"2024","unstructured":"Oladipo EK, Ojo TO, Elegbeleye OE, Bolaji OQ, Ogunlana AT, Olalekan EO, et al. Exploring nuclear proteins, viral capsid protein, and early antigen protein using immunoinformatic and molecular modeling approaches to design a vaccine candidate against Epstein-Barr virus. Sci Rep. 2024;14(1):16798. https:\/\/doi.org\/10.1038\/s41598-024-66828-x.","journal-title":"Sci Rep"},{"issue":"14","key":"407_CR47","doi-asserted-by":"publisher","first-page":"16547","DOI":"10.1021\/acsomega.4c00425","volume":"9","author":"AR Rizarullah","year":"2024","unstructured":"Rizarullah AR, Giri-Rachman EA, Hertadi R. Designing a novel multiepitope vaccine from human papilloma virus E1 and E2 proteins for Indonesia with immunoinformatics and molecular dynamics approaches. ACS Omega. 2024;9(14):16547\u201362. https:\/\/doi.org\/10.1021\/acsomega.4c00425.","journal-title":"ACS Omega"},{"issue":"20","key":"407_CR48","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.3390\/cancers13205189","volume":"13","author":"M Bauer","year":"2021","unstructured":"Bauer M, Jasinski-Bergner S, Mandelboim O, Wickenhauser C, Seliger B. Epstein-Barr virus-associated malignancies and immune escape: The role of the tumor microenvironment and tumor cell evasion strategies. Cancers. 2021;13(20):5189. https:\/\/doi.org\/10.3390\/cancers13205189.","journal-title":"Cancers"},{"key":"407_CR49","doi-asserted-by":"publisher","first-page":"123407","DOI":"10.1016\/j.ijbiomac.2023.123407","volume":"233","author":"A Beygmoradi","year":"2023","unstructured":"Beygmoradi A, Homaei A, Hemmati R, Fernandes P. Recombinant protein expression: Challenges in production and folding related matters. Int J Biol Macromol. 2023;233:123407. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123407.","journal-title":"Int J Biol Macromol"},{"issue":"W1","key":"407_CR50","doi-asserted-by":"publisher","first-page":"W174","DOI":"10.1093\/nar\/gkv342","volume":"43","author":"J Yang","year":"2015","unstructured":"Yang J, Zhang Y. I-TASSER server: New development for protein structure and function predictions. Nucleic Acids Res. 2015;43(W1):W174\u201381. https:\/\/doi.org\/10.1093\/nar\/gkv342.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"407_CR51","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1021\/ct300962x","volume":"9","author":"V Mirjalili","year":"2013","unstructured":"Mirjalili V, Feig M. Protein structure refinement through structure selection and averaging from molecular dynamics ensembles. J Chem Theory Comput. 2013;9(2):1294\u2013303. https:\/\/doi.org\/10.1021\/ct300962x.","journal-title":"J Chem Theory Comput"},{"key":"407_CR52","doi-asserted-by":"publisher","unstructured":"Wiederstein M, Sippl MJ. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007;W407\u201310. https:\/\/doi.org\/10.1093\/nar\/gkm290. 35(Web Server issue).","DOI":"10.1093\/nar\/gkm290"},{"key":"407_CR53","doi-asserted-by":"publisher","first-page":"1091571","DOI":"10.3389\/fped.2022.1091571","volume":"10","author":"L Liu","year":"2022","unstructured":"Liu L, Wang Y, Wang W, Ying W, Sun B, Wang X, et al. Increased expression of the TLR7\/9 signaling pathways in chronic active EBV infection. Front Pediatr. 2022;10:1091571. https:\/\/doi.org\/10.3389\/fped.2022.1091571.","journal-title":"Front Pediatr"},{"issue":"4","key":"407_CR54","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783\u2013801. https:\/\/doi.org\/10.1016\/j.cell.2006.02.015.","journal-title":"Cell"},{"issue":"5","key":"407_CR55","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol. 2010;11(5):373\u201384. https:\/\/doi.org\/10.1038\/ni.1863.","journal-title":"Nat Immunol"},{"key":"407_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13721-025-00721-z","volume":"15","author":"Y Ysrafil","year":"2026","unstructured":"Ysrafil Y, Alexandra FD, Trinovita E, Fatmaria F, Frethernety A, Syahputra D, et al. Unravelling potential of Peronema canescens Jack on hypertension: an integrative study of network pharmacology, molecular docking and dynamics. Netw Model Anal Health Inf Bioinform. 2026;15:35. https:\/\/doi.org\/10.1007\/s13721-025-00721-z.","journal-title":"Netw Model Anal Health Inf Bioinform"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00407-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00407-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00407-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:57:44Z","timestamp":1788512264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00407-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00407-1","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"68"}}